Abstract
In pelvic diseases, pain is a common and debilitating symptom with variable etiology. It can occur suddenly, sharply, and briefly (acute pelvic pain) or over the long term (chronic pelvic pain). Chronic pelvic pain refers to any constant or intermittent pelvic pain and is defined in a variety of ways. The most commonly used definitions consider both pain location and duration. In 1994, Campbell and Collett [1] defined it as “recurrent or constant pain in the lower abdominal region that has lasted for at least six months”. A similar definition was proposed by the American Congress of Obstetricians and Gynecologists: “non-cyclic pain of six or more months’ duration that localizes to the anatomic pelvis, anterior abdominal wall at or below the umbilicus, the lumbosacral back, or the buttocks, and is of sufficient severity to cause functional disability or lead to medical care” [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Campbell F, Collett BJ (1994) Chronic pelvic pain. Br J Anaesth 73(5):571–573
ACOG Committee on Practice Bulletins – Gynecology (2004) ACOG Practice Bulletin No. 51. Chronic pelvic pain. Obstet Gynecol 103(4):589–605
Costigan M, Scholz J, Woolf CJ (2009) Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 32:1–32
Zondervan KT, Yudkin PL, Vessey MP et al (1999) Prevalence and incidence of chronic pelvic pain in primary care: evidence from a national general practice database. Br J Obstet Gynaecol 106(11):1149–1155
Mathias SD, Kuppermann M, Liberman RF et al (1996) Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 87(3):321–327
Casey EB, Jellife AM, Le Quesne PM, Millett YL (1973) Vincristine neuropathy. Clinical and electrophysiological observations. Brain 96(1):69–86
Weng HR, Cordella J V, Dougherty PM (2003) Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain 103(1-2):131–138
Jacox A, Carr DB, Payne R (1992) Management of cancer pain. Clinical practice guideline no. 9. U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; Rockville: MD
Miaskowski C, Cleary J, Burney R et al (2005) Guideline for the management of cancer pain in adults and children. American Pain Society: Glenview
World Health Organization (1996) Cancer pain relief with a guide to opioid availability, 2nd ed. World Health Organization: Geneva
Jadad AR, Browman GP (1995) The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA 274(23):1870–1873
Zech DF, Grond S, Lynch J et al (1995) Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 63(1):65–76
Cleeland CS, Mendoza TR, Wang XS et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom inventory. Cancer 89(7):1634–1646
Derry S, Wiffen PJ, Aldington D, Moore RA (2015) Nortriptyline for neuropathic pain in adults. Cochrane Database Syst Rev 2015;1:CD011209
Lunn MP, Hughes RA, Wiffen PJ (2014) Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev 2014;1:CD007115
Moore RA, Wiffen PJ, Derry S et al (2014) Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2014;4:CD007938.
Ripamonti CI, Santini D, Maranzano E et al (2012) Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol 23(suppl 7):vii139–vii154
Caraceni A, Hanks G, Kaasa S and the European Palliative Care Research Collaborative (EPCRC) and the European Association for Palliative Care (EAPC) (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13(2):e58–e68
Camilleri M (2011) Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol 106(5):835–843
Cuomo A, Russo G, Esposito G et al (2014) Efficacy and gastrointestinal tolerability of oral oxycodone/naloxone combination for chronic pain in outpatients with cancer: an observational study. Am J Hosp Palliat Care 31(8):867–876
American Pain Foundation (2011) Breakthrough cancer pain: mending the break in the continuum of care. J Pain Palliat Care Pharmacother 25(3):252–264
World Health Organization (1997) Traitement de la douleur cancéreuse, World Health Organization: Geneva
Eisenberg E, Marinangeli F, Birkhahm J et al (2005) Time to modify the WHO analgesic leader? Pain Clin Update 13(5):1–4
Gómez-Cortéz MD, Rodríguez-Huertas F (2000) Reevaluación del segundo escalón de la escalera analgésica de la OMS. Rev Soc Esp Dolor 7(6):343–344
Vargas-Schaffer G (1999) Manejo y tratamiento del dolor oncológico. In: Vargas-Schaffer G, Esposito Quercia G, editors. Dolor y cuidados paliativos en oncologia. evaluación, manejo y tratamiento. Ediciones Expansión Científica G&S: Caracas, pp. 79–93
Grisell Vargas-Schaffer (2010) Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician 56(6):514–517
Krakowski I, Falcoff H, Gestin Y et al (1998) Recommandation pour une bonne pratique dans la prise en charge de la douleur du cancer chez l’adulte et l’enfant. Nice, Fr: Societé Française de la Douleur, Agency for Health Care Policy and Research, pp. 11–15
Caraceni A, Portenoy R K (1996) Pain management in patients with pancreatic carcinoma. Cancer 78(3 Suppl):639–653
de Leon-Casasola OA, Kent E, Lema MJ (1993) Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Pain 54(2):145–151
Plancarte R, Amescua C, Patt RB, Aldrete JA (1990) Superior hypogastric plexus block for pelvic cancer pain. Anesthesiology 73(2):236–239
Plancarte R, de Leon-Casasola OA, El-Helaly M et al (1997) Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth 22(6):562–568
Christo J, Hobelmann G (2009) Pelvic Pain. In: Smith HS (ed) Current Therapy in Pain. 1st edn. Saunders-Elsevier: Philadelphia, pp. 216–227
Waldman S (2009) Hypogastric Plexus Block. In: Waldman SD (ed) Pain review. 1st edn. Saunders-Elsevier: Philadelphia, pp. 538–541
Waldman S (2004) Atlas of Interventional Pain Management. 2nd edn. Saunders-Elsevier: Philadelphia
Plancarte R, Amescua C, Patt RB, Allende S (1990) Presacral blockade of the ganglion of Walter (ganglion impar). Anesthesiology 73(3A):A751
Gupta D, Jain R, Mishra S et al (2008) Ultrasonography reinvents the originally described technique for ganglion Impar neurolysis in perianal cancer pain. Anesth Analg 107(4):1390–1392
Malec-Milewska M, Horosz B, Kolęda I et al (2014) Neurolytic block of ganglion of Walther for the management of chronic pelvic pain. Wideochir Inne Tech Malo Inwazyjne 9(3):458-462
Ohhigashi S, Nishio T, Watanabe F, Matsusako M (2001) Experience with radiofrequency ablation in the treatment of pelvic recurrence in rectal cancer: report of two cases. Dis Colon Rectum 44(5):741–745
Wilsey C, Ashford NS, Dolin SJ (2002) Presacral neurolytic blocks for relief of pain from pelvic cancer: description and use of CT Guided lateral approach. Palliat Med 16(5):441–444
Zekry HA, Reddy SK (1999) Opioid and nonopioid therapy in cancer pain: the traditional and the new. Curr Rev Pain 3(3):237–247
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Italia
About this chapter
Cite this chapter
Cascella, M., Bifulco, F., Di Caprio, B., Cuomo, A. (2016). Pain Control and Palliative Treatments. In: Romano, G.M. (eds) Multimodal Treatment of Recurrent Pelvic Colorectal Cancer. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5767-8_13
Download citation
DOI: https://doi.org/10.1007/978-88-470-5767-8_13
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5766-1
Online ISBN: 978-88-470-5767-8
eBook Packages: MedicineMedicine (R0)